HealthVerity real-world data supports CDC study on HIV PrEP surveillance
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
The Marketplace model is winning: key insights from our webinar
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
The GLP-1 trend: What the real-world data reveals
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Link between prostate cancer, mental health: The importance of real-world insights
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
What everyone’s missing about data quality for AI and FDA readiness
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
HealthVerity at ISPOR 2025: Solving RWD Challenges in Pharma and HEOR
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
HealthVerity data strengthens regulatory submissions and clinical trials
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
Curated data in life sciences: the cornerstone of research readiness and precision
This is part three of a three-part series on the essential qualities of claims data for life...
Consistent data in life sciences: the key to reliable, reproducible, and actionable research
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
The best closed claims data for RWE and HEOR — HealthVerity taXonomy
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...